Literature DB >> 21383054

Legionella pneumophila type II secretion dampens the cytokine response of infected macrophages and epithelia.

Kessler McCoy-Simandle1, Catherine R Stewart, Jenny Dao, Sruti DebRoy, Ombeline Rossier, Paul J Bryce, Nicholas P Cianciotto.   

Abstract

The type II secretion (T2S) system of Legionella pneumophila is required for the ability of the bacterium to grow within the lungs of A/J mice. By utilizing mutants lacking T2S (lsp), we now document that T2S promotes the intracellular infection of both multiple types of macrophages and lung epithelia. Following infection of macrophages, lsp mutants (but not a complemented mutant) elicited significantly higher levels of interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), IL-10, IL-8, IL-1β, and MCP-1 within tissue culture supernatants. A similar result was obtained with infected lung epithelial cell lines and the lungs of infected A/J mice. Infection with a mutant specifically lacking the T2S-dependent ProA protease (but not a complemented proA mutant) resulted in partial elevation of cytokine levels. These data demonstrate that the T2S system of L. pneumophila dampens the cytokine/chemokine output of infected host cells. Upon quantitative reverse transcription (RT)-PCR analysis of infected host cells, an lspF mutant, but not the proA mutant, produced significantly higher levels of cytokine transcripts, implying that some T2S-dependent effectors dampen signal transduction and transcription but that others, such as ProA, act at a posttranscriptional step in cytokine expression. In summary, the impact of T2S on lung infection is a combination of at least three factors: the promotion of growth in macrophages, the facilitation of growth in epithelia, and the dampening of the chemokine and cytokine output from infected host cells. To our knowledge, these data are the first to identify a link between a T2S system and the modulation of immune factors following intracellular infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21383054      PMCID: PMC3088156          DOI: 10.1128/IAI.01077-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  121 in total

1.  Demonstration of the intracellular production of tissue-destructive protease by Legionella pneumophila multiplying within guinea-pig and human alveolar macrophages.

Authors:  C Rechnitzer; A Williams; J B Wright; A B Dowsett; N Milman; R B Fitzgeorge
Journal:  J Gen Microbiol       Date:  1992-08

2.  Investigation of the role of macrophages and endogenous interferon-gamma in natural resistance of mice against Legionella pneumophila infection.

Authors:  H Fujio; S Yoshida; H Miyamoto; M Mitsuyama; Y Mizuguchi
Journal:  FEMS Microbiol Immunol       Date:  1992-04

3.  Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.

Authors:  S J Skerrett; T R Martin
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages.

Authors:  D R Park; S J Skerrett
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

5.  Infectivity of Legionella pneumophila mip mutant for alveolar epithelial cells.

Authors:  N P Cianciotto; J K Stamos; D W Kamp
Journal:  Curr Microbiol       Date:  1995-04       Impact factor: 2.188

6.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide.

Authors:  J K Brieland; D G Remick; P T Freeman; M C Hurley; J C Fantone; N C Engleberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

7.  Cleavage of tumor necrosis factor-alpha by Legionella exoprotease.

Authors:  W Hell; A Essig; S Bohnet; S Gatermann; R Marre
Journal:  APMIS       Date:  1993-02       Impact factor: 3.205

8.  Legionella pneumophila protease inactivates interleukin-2 and cleaves CD4 on human T cells.

Authors:  C S Mintz; R D Miller; N S Gutgsell; T Malek
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

9.  Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease.

Authors:  J Brieland; P Freeman; R Kunkel; C Chrisp; M Hurley; J Fantone; C Engleberg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

10.  Effects of an isogenic Zn-metalloprotease-deficient mutant of Legionella pneumophila in a guinea-pig pneumonia model.

Authors:  J F Moffat; P H Edelstein; D P Regula; J D Cirillo; L S Tompkins
Journal:  Mol Microbiol       Date:  1994-06       Impact factor: 3.501

View more
  33 in total

1.  The major facilitator superfamily-type protein LbtC promotes the utilization of the legiobactin siderophore by Legionella pneumophila.

Authors:  Christa H Chatfield; Brendan J Mulhern; V K Viswanathan; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2011-12-08       Impact factor: 2.777

2.  Stenotrophomonas maltophilia Encodes a VirB/VirD4 Type IV Secretion System That Modulates Apoptosis in Human Cells and Promotes Competition against Heterologous Bacteria, Including Pseudomonas aeruginosa.

Authors:  Megan Y Nas; Richard C White; Ashley L DuMont; Alberto E Lopez; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

3.  Persistence of the bacterial pathogen Granulibacter bethesdensis in chronic granulomatous disease monocytes and macrophages lacking a functional NADPH oxidase.

Authors:  Jessica Chu; Helen H Song; Kol A Zarember; Teresa A Mills; John I Gallin
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

4.  Nuclease activity of Legionella pneumophila Cas2 promotes intracellular infection of amoebal host cells.

Authors:  Felizza F Gunderson; Celeste A Mallama; Stephanie G Fairbairn; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2014-12-29       Impact factor: 3.441

Review 5.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

6.  Type II Secretion Is Necessary for Optimal Association of the Legionella-Containing Vacuole with Macrophage Rab1B but Enhances Intracellular Replication Mainly by Rab1B-Independent Mechanisms.

Authors:  Richard C White; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 7.  The Secrets of Acinetobacter Secretion.

Authors:  Brent S Weber; Rachel L Kinsella; Christian M Harding; Mario F Feldman
Journal:  Trends Microbiol       Date:  2017-02-16       Impact factor: 17.079

Review 8.  Cardiomyocytes of the Heart and Pulmonary Veins: Novel Contributors to Asthma?

Authors:  Stephen Sai Folmsbee; Cara J Gottardi
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

9.  The Legionella pneumophila Dot/Icm-secreted effector PlcC/CegC1 together with PlcA and PlcB promotes virulence and belongs to a novel zinc metallophospholipase C family present in bacteria and fungi.

Authors:  Philipp Aurass; Maren Schlegel; Omar Metwally; Clare R Harding; Gunnar N Schroeder; Gad Frankel; Antje Flieger
Journal:  J Biol Chem       Date:  2013-03-01       Impact factor: 5.157

10.  Multiple Legionella pneumophila Type II secretion substrates, including a novel protein, contribute to differential infection of the amoebae Acanthamoeba castellanii, Hartmannella vermiformis, and Naegleria lovaniensis.

Authors:  Jessica Y Tyson; Meghan M Pearce; Paloma Vargas; Sreya Bagchi; Brendan J Mulhern; Nicholas P Cianciotto
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.